SUPPLEMENTAL EXPERIMENTAL PROCEDURES Plasmids and Proteins
Rad51 point mutations were introduced using QuikChange Site-Directed Mutagenesis Kit (Stratagene) according to the manufacturer's protocol, and were confirmed by DNA sequencing. For mammalian expression, human Rad51 was cloned into pcDNA5/FRT vector (Invitrogen) with or without FLAG epitope at N-terminus. Rad51 NTD (1-86) variants were PCR cloned into pET11d (Stratagene) or pGEX-4T-3 (GE Healthcare), and the recombinant proteins were purified following standard protocols using TALON Metal Affinity Resin (Clontech) or Glutathione Sepharose (GE Healthcare). Recombinant full-length Rad51 (Baumann et al., 1997) , ATPase core Rad51 (Esashi et al., 2007) , and Nbs1 (1-382) fragments (Lloyd et al., 2009) were prepared as described previously.
Recombinant full-length FLAG-Nbs1 was a kind gift from Dr Tanya Paull, and recombinant Plk1 and CK2 protein were purchased from Abcam and New England BioLabs respectively. pCBASceI (Richardson et al., 1998) was obtained from Addgene (gene ID: 26477) . Genes encoding AAVS1 targeting zinc-finger domains are synthesised from GeneArt according to the previously described amino acid sequence (Hockemeyer et al., 2009) , and cloned into pZFN1 and pZFN2 (Sigma, kind gifts from Prof. Peter Cook) at Acc65I-BamHI sites. To generate pZDonor-AAVS1-GFP, a GFP gene was PCR cloned into pZDonor-AAVS1-Puromycin (Sigma) at BglII-NcoI sites.
Antibodies
Primary antibodies for western blot analyses were obtained from following sources. Anti-BRCA2 (OP95, Calbiochem), anti-Cyclin E (M-20, sc-481, Santa Cruz), anti-Cyclin A (AT10-3, a kind gift from Tim Hunt), anti-FLAG (M2, Sigma-Aldrich), anti-GST-HRP (B-14, Santa Cruz), anti-H2AX (2595, Cell Signaling), anti--H2AX (JBW301, Upstate), anti-Lamin (L1293, Sigma-Aldrich), anti-Nbs1 (34/NBS1, BD Biosciences), anti-Plk1 (A300-251A, Bethyl Laboratories), anti-Plk1 (36-298, Sigma-Aldrich), antiphospho-T210 Plk1 (558400, BD Biosciences), anti-phospho-S10 Histone H3 (9701, Cell Signalling), anti-PALB2 (A301-246A, Bethyl Laboratories), anti-Rad51 (14B4, Abcam), and anti-Rad51 (FBE2, a kind gift from Stephen West). Phosphopeptide antibodies were raised in rabbit against the KLHconjugated phosphopeptide (NH2)-CEANADTpSVEEE-(COOH) for S14 phospho-specific antibody,
CEANADpTpSVEEES-(COOH) for T13 and S14 double phospho-specific antibody (Biogenes).
Antibodies were affinity purified using phosphopeptide columns prepared with SulfoLink Kit (Pierce).
After elution with ImmunoPure Gentle Ag/Ab Elution Buffer (Pierce), antibodies were dialysed against TBS and contaminating non-phosphospecific antibody was affinity depleted by passing through a column cross-linked with non-phosphopeptide (NH2)-CEANADTSVEEE-(COOH). The eluted phospho-specific antibodies were then enriched by dialysis against TBS containing 50% glycerol.
Mass Spectrometry Analysis for Identification of Phosphorylation Sites
Polyacrylamide gel slices (1-2 mm) containing the purified proteins were prepared for mass spectrometric analysis using the Janus liquid handling system (PerkinElmer, UK). Briefly, the excised protein gel pieces were placed in a well of a 96-well microtitre plate and destained with 50% v/v acetonitrile and 50 mM ammonium bicarbonate, reduced with 10 mM DTT, and alkylated with 55 mM iodoacetamide. After alkylation, proteins were digested with 6 ng/µL Trypsin (Promega, UK) overnight at 37°C. The resulting peptides were extracted in 2% v/v formic acid, 2% v/v acetonitrile.
The digest was analysed by nano-scale capillary LC-MS/MS using a nanoAcquity UPLC (Waters, UK)
to deliver a flow of approximately 300 nL/min. A C18 Symmetry 5 µm, 180 µm x 20 mm µ-Precolumn (Waters, UK), trapped the peptides prior to separation on a C18 BEH130 1.7 µm, 75 µm x 100 mm analytical UPLC column (Waters, UK). Peptides were eluted with a gradient of acetonitrile. The analytical column outlet was directly interfaced via a modified nano-flow electrospray ionisation source, with a hybrid linear quadrupole fourier transform mass spectrometer (LTQ Orbitrap XL/ETD, ThermoScientific, San Jose, USA). Data dependent analysis was carried out, using a resolution of 30,000 for the full MS spectrum, followed by eight MS/MS spectra in the linear ion trap. MS spectra were collected with an automatic target gain control of 5x10 5 and a maximum injection fill time of 100 ms over a m/z range of 300-2000. MS/MS scans were collected using an automatic gain control value of 4x10 4 and a threshold energy of 35 for collision induced dissociation. LC-MS/MS data were then searched against a protein database (UniProt KB) using the Mascot search engine programme (Matrix Science, UK) (Perkins et al., 1999) . Database search parameters were set with a precursor tolerance of 5 ppm and a fragment ion mass tolerance of 0.8 Da. One missed enzyme cleavage was allowed and variable modifications for oxidized methionine, carbamidomethyl cysteine, pyroglutamic acid, phosphorylated serine, threonine and tyrosine were included. MS/MS data were validated using the Scaffold programme (Proteome Software Inc., USA) (Keller et al., 2002) . All data were additionally interrogated manually.
Analysis of Cell Cycle Distribution by Flow Cytometry
U2OS cells were pulse labeled with 10 μM bromodeoxyuridine (BrdU) (Sigma-Aldrich) for 30 min prior to harvesting by trypsinisation. Cells were washed in PBS and fixed with ice cold 70% ethanol for 30 min on ice. Fixed cells were washed in PBS and DNA was denatured with 2 N HCl containing 0.5%
Triton X-100 for 30 min at room temperature, followed by neutralisation with 0.1M Na 2 B 4 O 7 at pH 8.5. 
Immunofluorescence Microscopy
Cells were seeded at a density of 1 x 10 5 cells in 12-well plates containing coverslips 24 hours after siRNA transfection. After overnight incubation, cells were irradiated with 4 Gy, and coverslips were recovered after 2.5 hours. The cells were pre-extracted for 1 min in pre-extraction buffer (80 mM NaCl, 3 mM MgCl 2 ) and fixed with 4% paraformaldehyde in PBS, followed by permeabilisation with 0.5% Triton X-100 in PBS. After blocking in antibody dilution buffer (1% BSA, 0.2% cold fish skin gelatin and 0.05% Triton X-100 in PBS), primary antibody against Rad51 and -H2AX were applied. 
Small Interfering RNAs
Following small interfering RNAs were synthesized from Sigma-Aldrich, and a mixture of two siRNA was used to down regulate indicated gene product.
Human siRad51 
Oligonucleotides Used for RAD51 Mutagenesis
Oligonucleotides used for RAD51 mutagenesis were designed using the QuikChange Primer Design tool (Stratagene), and synthesized by Sigma-Aldrich. ) or its variant harbouring S14E substitution (FL S14E ) was phosphorylated in vitro with CK2 or Plk1, and Nbs1 interaction was tested by far-western blotting using recombinant Nbs1 as described in Figure 5A. (B) Similarly, Rad51 NTD variants with S14 substitution were phosphorylated with CK2, and its interaction with Nbs1 was detected by far-western blotting. Consistent with the altered CK2-mediated phosphorylation of Rad51 S14 variants shown in Figure 3D , increased Nbs1 interactions with CK2 phosphorylated S14D or S14E NTD, but reduced interaction with S14A NTD, were detected. (F) An example of HR assay depicted in Figure 6H , showing a representative flow cytometric profile of U2OS-SCR18 cells exogenously expressing wild-type Rad51.
(G and H) Examples of DSB-mediated gene targeting assay depicted in Figure 6J , showing a representative flow cytometric profile of U2OS cells exogenously expressing wild-type Rad51 (G) or EUFA423 cells exogenously expressing wild-type Rad51 (H).
